Hutch News
Results per Page:
Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine
Study result moves scientists closer to developing elusive HIV vaccine
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 24, 2023
Mosaic HIV immunogens boost the breadth of vaccine immune responses
From the Gilbert and McElrath Labs, Vaccine and Infectious Disease Division
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies
Dr. Larry Corey receives Alexander Fleming Award
Virologist honored by peers for his lifetime achievements against infectious diseases
Does HIV disease progression differ by ancestry?
From Drs. Shuying (Sue) Li and Peter Gilbert, Vaccine and Infectious Disease Division
License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover
From the Emerman and Henikoff Labs, Pathogen Associated Malignancies and Cancer Basic Biology Programs, Cancer Consortium.
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation
NIAID director’s determined spirit recognized with honorary Hutch Award
Tip Sheet: Fred Hutch experts and omicron, closing gaps in indigenous health disparities, new leaders in DEI and data science — and ASH 2021
Summaries of recent Fred Hutch research findings and other news
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research
HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor.
A new path forward: A potential route to effective HIV vaccines
From the Overbaugh Lab, Human Biology Division
Tip Sheet: Massive unmet needs in COVID-19 treatment, osteoporosis drugs for breast cancer, new bladder cancer target — and AIDS at 40
Summaries of recent Fred Hutch research findings and other news
HIV antibody trial results offer 'proof of concept'
Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
No ‘black diamond’ ski slopes for the TRIM5α antiviral protein
From the Malik and Emerman labs, Basic Sciences Division
When COVID-19 crosses paths with HIV
Survivors of one pandemic now brace for a new one
Multi-step HIV-1 vaccines
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
T cells as biomarkers for hepatitis B disease prognosis
From the Newell lab, Vaccine and Infectious Disease Division
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more